Which action of atorvastatin should the nurse explain to the patient?

Which action of atorvastatin should the nurse explain to the patient?

• A. Binding with bile acids to form an insoluble complex that is excreted
• B. Blocking the enzyme that is involved in cholesterol synthesis
• C. Stimulating the breakdown of lipoproteins from the tissues
• D. Decreasing dietary cholesterol absorption from the small intestine

Answer: (B)

Atorvastatin is classified as a statin, which means its primary mechanism of action involves inhibiting an enzyme called HMG-CoA reductase. This enzyme is crucial for the synthesis of cholesterol in the liver. By blocking this enzyme, atorvastatin effectively reduces the overall cholesterol production within the liver, leading to a decrease in the levels of low-density lipoprotein (LDL) cholesterol in circulation. This inhibition not only promotes a lowering of LDL cholesterol levels but also helps in increasing the uptake of LDL from the blood into the liver, further contributing to lower serum cholesterol levels. Therefore, when explaining atorvastatin's action to the patient, it is important to highlight its role in blocking cholesterol synthesis, as this is central to its efficacy in managing dyslipidemia and reducing cardiovascular risk. The other options describe functions associated with different classes of lipid-lowering agents or biological processes not directly related to the action of atorvastatin. For instance, binding with bile acids pertains to the mechanism of bile acid sequestrants, while stimulating lipoprotein breakdown or decreasing dietary cholesterol absorption reflects actions associated with other types of lipid-lowering medication. Thus, the correct choice emphasizes atorvastatin’s specific role as an HMG-CoA

Atorvastatin is classified as a statin, which means its primary mechanism of action involves inhibiting an enzyme called HMG-CoA reductase. This enzyme is crucial for the synthesis of cholesterol in the liver. By blocking this enzyme, atorvastatin effectively reduces the overall cholesterol production within the liver, leading to a decrease in the levels of low-density lipoprotein (LDL) cholesterol in circulation.

This inhibition not only promotes a lowering of LDL cholesterol levels but also helps in increasing the uptake of LDL from the blood into the liver, further contributing to lower serum cholesterol levels. Therefore, when explaining atorvastatin's action to the patient, it is important to highlight its role in blocking cholesterol synthesis, as this is central to its efficacy in managing dyslipidemia and reducing cardiovascular risk.

The other options describe functions associated with different classes of lipid-lowering agents or biological processes not directly related to the action of atorvastatin. For instance, binding with bile acids pertains to the mechanism of bile acid sequestrants, while stimulating lipoprotein breakdown or decreasing dietary cholesterol absorption reflects actions associated with other types of lipid-lowering medication. Thus, the correct choice emphasizes atorvastatin’s specific role as an HMG-CoA